Macrocyclics is Biotechnology in United States that focus on peptide fragments business. Founded in 1995. They cover business area such as manufacturer, custom chelate agent, development, new chelation chemistry platform, advancement, diagnostic and therapeutic medicine, its product, a line, bifunctional ligand, combination, monoclonal antibody, peptide fragment.
1995
( 29 years old in 2024 )
Peptide Fragments
-
1309 Record Crossing
Dallas, TX 75235
United States
Private
manufacturercustom chelate agentdevelopmentnew chelation chemistry platformadvancementdiagnostic and therapeutic medicineits producta linebifunctional ligandcombinationmonoclonal antibodypeptide fragment
* We use standard office opening hours in near Macrocyclics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Macrocyclics is Biotechnology business from United States that founded in 1995 (29 years old in 2024), Macrocyclics business is focusing on Peptide Fragments.
Macrocyclics headquarter office and corporate office address is located in 1309 Record Crossing Dallas, TX 75235 United States.
Macrocyclics was founded in United States.
In 2024, Macrocyclics is currently focus on peptide fragments sector.
Above is snippet of Google Trends for "peptide fragments" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Macrocyclics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
